OPKO Health
Healthcare Services · Florida, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
4400 Biscayne Blvd, Miami, Florida, 3313...Phone Number
(305) 575-4100Website
www.opko.comRevenue
$587.9 MillionStock Symbol
OPKIndustry
ZI Rank: 8
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
10
11
9
8
9
8
About OPKO Health
OPKO Health, Inc. is a fully integrated, diversified healthcare company founded in 2006 and headquartered in Miami, Florida. The company operates across two primary segments Pharmaceuticals and Diagnostics engaged in the discovery, development, and commercialization of medicines and diagnostic testing services for serious diseases. Its diagnostics operations include a large clinical reference laboratory offering a broad range of testing services spanning molecular diagnostics, genetics, anatomical pathology, and women's health. Its pharmaceutical operations focus on developing and commercializing treatments across endocrinology and other therapeutic areas, as well as advancing multispecific antibody therapies for oncology and infectious disease through its biotechnology subsidiary. OPKO Health operates across the United States and internationally, with established pharmaceutical platforms in multiple countries. The company trades on the NASDAQ under the ticker symbol OPK.Explore more
OPKO Health Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OPKO Health your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on OPKO Health recently announced quarterly report
Funding: Get notified immidiatlly once OPKO Health has new funding data
Congratulate Masked Content for being promoted to Masked Content at OPKO Health
Check out if OPKO Health is spiking on competitors!
Product Launch: Get notified when OPKO Health launches new products
Website visits: Recent activity has been detected on your website
OPKO Health, which may be a good buyer, showed buying intent in Masked Content Topic
Check if OPKO Health has recently received funding, and reach out quickly before it becomes old news!
Click to see if OPKO Health had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at OPKO Health
Find 2 more new buyers
Compare Similar Companies to OPKO Health
Compare insights from companies similar to OPKO Health, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$232.5M
1K - 5K
Public
$195.5M
2010
EL
Ewa Lipinska-KowalikSenior Executive Administartive Partner To CEO
Company Profile Activity
Activity Insights
OPKO Health is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
OPKO Health is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about OPKO Health.
OPKO Health financials insights
Gather financial insights about OPKO Health, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$62.3M
2026
Debt
$125M
OPKO Health Tech Stack
A closer look at the technologies used by OPKO Health
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Pain Point
OPKO Health is facing a delay in broader market expansion for its diagnostics business, as the company is awaiting definitive CMS approval for changes to Medicare reimbursement requirements before actively pursuing primary care opportunities, with the anticipated volume and reimbursement growth now expected to materialize in 2027 and beyond rather than in the current year.
Forecasting, Barriers, Finance, Financial Operations, Risk
Project
OPKO Health announced that MDX2001 has enrolled 39 patients to date in its Phase I trial, with the company now focusing recruitment on tumor types more likely to respond to immunotherapy including non-small cell lung cancer, certain renal carcinomas, and potentially ovarian cancer while also exploring subcutaneous injection alongside IV administration to enable higher dosing with improved tolerability.
Medical Research, Pharmaceuticals, Clinical Operations
Partnership
Partnership
OPKO Health News & Media
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upsideCocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026OPKO Health Inc (OPK) Q2 2026 Earnings Call Highlights: Strong Pharmaceutical Growth and ...
OPKO Health Inc (OPK) reports significant revenue growth in pharmaceuticals and a notable reduction in net loss, despite challenges in diagnostics.OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
Conference Call to Begin Today at 4:30 p.m. ET Conference Call to Begin Today at 4:30 p.m. ET
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OPKO Health
Sign Up For FreeTo access detailed company insights
OPKO Health, Inc. is a fully integrated, diversified healthcare company founded in 2006 and headquartered in Miami, Florida. The company operates across two primary segments Pharmaceuticals and Diagnostics engaged in the discovery, development, and commercialization of medicines and diagnostic testing services for serious diseases. Its diagnostics... Read More
